Otoimmün Nörolojik Kanalopatiler

Kim JB. Channelopathies. Korean journal of pediatrics, 2014, 57.1: 1.

Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron, 2006, 52.1: 123-138.

Kleopa KA. Autoimmune channelopathies of the nervous system. Current neuropharmacology, 2011, 9.3: 458-467.

Buckley C, Vincent A. Autoimmune channelopathies. Nature clinical practice Neurology, 2005, 1.1: 22-33.

Vincent A. Developments in autoimmune channelopathies. Autoimmunity Reviews, 2013, 12.6: 678-681.

Trouth AJ, Alok D, Solieman N et al. Myasthenia gravis: a review. Autoimmune diseases, 2012, 2012.

O'connell K, Ramdas S, Palace J. Management of juvenile myasthenia gravis. Frontiers in Neurology, 2020, 11: 558150.

Peragallo JH. Pediatric myasthenia gravis. In: Seminars in Pediatric Neurology. WB Saunders, 2017. p. 116-121.

Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. Journal of medicine and life, 2021, 14.1: 7.

Dresser L ,Wlodarski R, Rezania K and Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. Journal of clinical medicine, 2021, 10.11: 2235.

Hayashi M. Childhood myasthenia gravis in Japan: Pathophysiology and treatment options. Clinical and Experimental Neuroimmunology, 2023, 14.4: 185-194.

Finnis MF and Jayawant S. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune diseases, 2011, 2011.

Yangın M, Zorlu Y, Severcan F. Diagnosis and treatment methods of autoimmune myasthenia gravis: a systematic review. Aurum Journal of Health Sciences, 2022, 4.2: 104-116.

Chan KH, Lachance DH, Harper CM, And Lennon VA. Frequency of seronegativity in adult‐acquired generalized myasthenia gravis. Muscle & nerve, 2007, 36.5: 651-658.

Rousseff RT. Diagnosis of myasthenia gravis. Journal of clinical medicine, 2021, 10.8: 1736.

AAEM Quality Assurance Committee, & American Association of Electrodiagnostic Medicine. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle & nerve, 2001, 24(9), 1239-1247.

Yang ZX, Xu KL, and Xiong H. Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis. Experimental and Therapeutic Medicine, 2015, 9(4), 1363-1368.

Pascuzzi, RM, Bodkin, CL. Myasthenia gravis and Lambert-Eaton myasthenic syndrome: New developments in diagnosis and treatment. Neuropsychiatric Disease and Treatment, 2022, 3001-3022.

Morgan-Followell, B, & de Los Reyes E. Child neurology: diagnosis of Lambert-Eaton myasthenic syndrome in children. Neurology, 2013, 80(21), e220-e222.

Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa, A, and Suzuki S. The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome. Clinical and Experimental Neuroimmunology, 2022, 14(1), 19-27.

Pruetarat N, Netbaramee W, Pattharathitikul S, and Veeravigrom M. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study. Brain and Development, 2019, 41(5), 436-442.

Hardy D. Autoimmune encephalitis in children. Pediatric Neurology, 2022, 132, 56-66.

Garg D, Mohammad SS, and Sharma S. Autoimmune encephalitis in children: an update. Indian pediatrics, 57, 662-670.

Giri YR, Parrill A, Damodar S, Fogel J, Ayed N, Syed M and Hashmi S. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents: a systematic review and quantitative analysis of reported cases. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 2021, 30(4), 236.

Bacchi S, Franke K, Wewegama D, Needham E, Patel S, and Menon D. Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. Journal of Clinical Neuroscience, 2018, 52, 54-59.

Nosadini, M, Thomas, T, Eyre M et al. International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis. Neurology: Neuroimmunology & Neuroinflammation, 2021, 8(5), e1052.

Santos FPST, Nascimento BR, Calderaro DC, Ferreira GA, and Correa H. Neuropsychiatric syndromes in childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis. JCR: Journal of Clinical Rheumatology, 2021, 27.5: 206-214.

Appenzeller S, Pereira DR, Julio PR, Reis F, Rittner L, and Marini R. Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus. The Lancet Child & Adolescent Health, 2022, 6.8: 571-581.

Sarwar S, Mohamed AS, Rogers S et al. Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus, 2021, 13.9.

Haberlandt E, Bast T, Ebner A et al. Limbic encephalitis in children and adolescents. Archives of disease in childhood, 2011, 96.2: 186-191.

Sabanathan S, Abdel‐Mannan O, Mankad K et al. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study. Annals of clinical and translational neurology, 2022, 9.1: 67-78.

Budhram A, Leung A, Nicolle MW, and Burneo JG. Diagnosing autoimmune limbic encephalitis. Cmaj, 2019, 191.19: E529-E534.

Surana S, Kumar R, Pitt M et al. Acquired neuromyotonia in children with CASPR 2 and LGI 1 antibodies. Developmental Medicine & Child Neurology, 2019, 61.11: 1344-1347.

Nikolaus M, Jackowski-Dohrmann S, Prüss H, Schuelke M, and Knierim E. Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child. Neurology, 2018, 90.4: 183-185.

Ferilli MAN, Paparella R, Morandini I et al. Pediatric neuromyelitis optica spectrum disorder: case series and literature review. Life, 2021, 12.1: 19.

Paolilo RB, Paz, JAD, Apóstolos-Pereira SL, Rimkus CDM, Callegaro D, and Sato DK. Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents. Arquivos de Neuro-psiquiatria, 2023, 81: 201-211.

Zhang Z, Zhou H, Liu X, Liu L, Shu S, and Fang F. Identification of the clinical and neuroimaging characteristics in children with neuromyelitis optica spectrum disorders: a case series. Translational Pediatrics, 2021, 10.10: 2459.

Carnero Contentti E, and Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. Journal of Neuroinflammation, 2021, 18.1: 208.

Comperat L, Pegat A, Honnorat J, and Joubert B. Autoimmune neuromyotonia. Current Opinion in Neurology, 2022, 35.5: 597-603.

Gonzalez G, Barros G, Russi ME, Nuñez A, and Scavone C. Acquired neuromyotonia in childhood: case report and review. Pediatric neurology, 2008, 38.1: 61-63.

Abokrysha NT, Farouk Hussein AA, and Magdy R. Childhood onset of acquired neuromyotonia: association with vitamin D deficiency. International Journal of Neuroscience, 2020, 130.6: 631-634.

Kilic MA, Yoruk Yildirim ZN, Oner A et al. Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome. Journal of Neurology, 2021, 268.12: 4492-4494.

Jiang Y, Tan C, Li T et al. Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children. Frontiers in Pediatrics, 2022, 10: 815976.

Golden EP, Vernino S. Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances. Clinical Autonomic Research, 2019, 29.3: 277-288.

Kuki I, Kawawaki H, Okazaki S, Hattori Y, Horino A, Higuchi O, and Nakane S. Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain and Development, 2016, 38.6: 605-608.

Nakane S, Mukaino A, Higuchi O et al. Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment. Expert Review of Neurotherapeutics, 2018, 18.12: 953-965.